Retrospective analysis of the prognostic role of tissue eosinophil and mast cells in Hodgkin's lymphoma

被引:25
作者
Keresztes, Katalin
Szollosi, Zoltan
Simon, ZSofia
Tarkanyi, Ilona
Nemes, Zoltan
Illes, Arpad
机构
[1] Univ Debrecen, Dept Med 3, Med & Hlth Ctr, H-4004 Debrecen, Hungary
[2] Univ Debrecen, Dept Pathol, Med & Hlth Ctr, Debrecen, Hungary
关键词
Hodgkin's lymphoma; mast cell; eosinophil cell;
D O I
10.1007/BF02893504
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The composition of reactive cell populations, which constitute the majority of tumor load in Hodgkin's lymphoma (HL), can influence the prognosis of the disease. Besides widely accepted and applied prognostic scores, the authors evaluate biological factors that may have a prognostic impact. Previous data indicate that the rate of eosinophils and mast cells in the reactive cell population, determined already at diagnosis, can be used for this purpose. Histological samples from 104 patients with HL with an average follow-up period of 110 (24-214) months were retrospectively analyzed. Mast cell positivity was associated with better overall survival, although this difference was only of borderline statistical significance (p=0.092). No significant difference was found in parameters like overall survival (OS, p=0.906) or event-free survival (EFS, p=0.307) of eosinophil-positive vs. -negative cases or in EFS (p=0.742) of mast cell-positive vs. -negative individuals (criterion for a positive specimen was more than 5% of appropriate cells in the reactive cell population). Looking at the effect of eosinophilia and mastocytosis together, there was no significant difference between the subgroups categorized according to the combined presence of the two cell types. It seems that tissue eosinophil and mast cell predominance have no prognostic value that could be used in clinical practice, although a tendency for correlation of mast cell positivity with overall survival could be seen. For a definitive statement, multicenter studies should be performed involving a higher number of patients suffering from HL.
引用
收藏
页码:237 / 242
页数:6
相关论文
共 26 条
[1]   Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease [J].
Axdorph, U ;
Porwit-MacDonald, A ;
Grimfors, G ;
Björkholm, M .
LEUKEMIA & LYMPHOMA, 2001, 42 (05) :1055-+
[2]   Eosinophils and antitumour response [J].
Costello, R ;
O'Callaghan, T ;
Sébahoun, G .
REVUE DE MEDECINE INTERNE, 2005, 26 (06) :479-484
[3]  
DAMORE ESG, 1992, ARCH PATHOL LAB MED, V116, P856
[4]   INFILTRATION OF EOSINOPHILS IN HODGKINS-DISEASE INVOLVED LYMPH-NODES PREDICTS PROGNOSIS [J].
ENBLAD, G ;
SUNDSTROM, C ;
GLIMELIUS, B .
HEMATOLOGICAL ONCOLOGY, 1993, 11 (04) :187-193
[5]   Expression of CCL5/rantes by Hodgkin and reed-sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue [J].
Fischer, M ;
Juremalm, M ;
Olsson, N ;
Backlin, C ;
Sundström, C ;
Nilsson, K ;
Enblad, G ;
Nilsson, G .
INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (02) :197-201
[6]   Angiogenesis and mast cells in Hodgkin lymphoma [J].
Glimelius, I ;
Edström, A ;
Fischer, M ;
Nilsson, G ;
Sundström, C ;
Molin, D ;
Amini, RM ;
Enblad, G .
LEUKEMIA, 2005, 19 (12) :2360-2362
[7]   Expression of CCL28 by Reed-Sternberg cells defines a major subtype of classical Hodgkin's disease with frequent infiltration of eosinophils and/or plasma cells [J].
Hanamoto, H ;
Nakayama, T ;
Miyazato, H ;
Takegawa, S ;
Hieshima, K ;
Tatsumi, Y ;
Kanamaru, A ;
Yoshie, O .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (03) :997-1006
[8]   A prognostic score for advanced Hodgkin's disease [J].
Hasenclever, D ;
Diehl, V .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1506-1514
[9]   Macrophage-derived chemokine expression in classical Hodgkin's lymphoma: Application of tissue microarrays [J].
Hedvat, CV ;
Jaffe, ES ;
Qin, J ;
Filippa, DA ;
Cordon-Cardo, C ;
Tosato, G ;
Nimer, SD ;
Teruya-Feldstein, J .
MODERN PATHOLOGY, 2001, 14 (12) :1270-1276
[10]   ERYTHROCYTE SEDIMENTATION-RATE PREDICTS EARLY RELAPSE AND SURVIVAL IN EARLY-STAGE HODGKIN DISEASE [J].
HENRYAMAR, M ;
FRIEDMAN, S ;
HAYAT, M ;
SOMERS, R ;
MEERWALDT, JH ;
CARDE, P ;
BURGERS, JMV ;
THOMAS, J ;
MONCONDUIT, M ;
NOORDIJK, EM ;
BRON, D ;
REGNIER, R ;
DEPAUW, BE ;
TANGUY, A ;
COSSET, JM ;
DUPOUY, N ;
TUBIANA, M .
ANNALS OF INTERNAL MEDICINE, 1991, 114 (05) :361-365